1. PO-1351 Patterns of local relapse following tumor-targeted dose escalation for localized prostate cancer. (August 2021) Authors: Padayachee, J.; Sanmamed, N.; Lee, J.; Liu, Z.; Berlin, A.; Craig, T.; Lao, B.; Rink, A.; Bayley, A.; Catton, C.; Sundaramurthy, A.; Foltz, W.; McPartlin, A.; Ghai, S.; Atenafu, E.; Gospodarowicz, M.; Warde, P.; Helou, J.; Raman, S.; Ménard, C. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-1119: Sexual Toxicity in Cervix Cancer Survivors Treated with Chemo-Radiation and MR-guided Brachytherapy. (November 2020) Authors: Conway, J.; Conroy, L.; Ferguson, S.; Zia, A.; Liu, A.; Weiss, J.; Rink, A.; Jennifer, C. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PV-0147 MRI-guided salvage HDR brachytherapy for locally recurrent prostate cancer. (April 2019) Authors: Joseph, L.; Sundaramurthy, A.; Berlin, A.; Helou, J.; Menard, C.; Warde, P.; Catton, C.; Lao, B.; Bayley, A.; Rink, A.; Beiki-Ardakani, A.; Chung, P. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-0038 Outcomes in focal vs. dose-painted salvage HDR brachytherapy for locally recurrent prostate cancer. (May 2021) Authors: Navarro, I.; Joseph, L.; Liu, Z.; Taussky, D.; Delouya, G.; Barkati, M.; Beauchemin, M.; Niazi, T.; Berlin, A.; Helou, J.; Raman, S.; Beliveau-Nadeau, D.; Kadoury, S.; Rink, A.; Chung, P.; Ménard, C. Journal: Radiotherapy and oncology Issue: Volume 158(2021)Supplement 1 Page Start: S24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PV-0258: Dose to the Bladder Neck: Impact on Urinary Toxicity after MRI-guided HDR Prostate Brachytherapy. (April 2018) Authors: Sanmamed, N.; Chung, P.; Berlin, A.; Borg, J.; Lao, B.; Weersink, R.; Simeonov, A.; Rink, A.; Menard, C.; Helou, J. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-0960: Making MR-guided cervix cancer brachytherapy efficient: Are plan adaptation & daily planning needed?. (April 2016) Authors: Skliarenko, J.; Carlone, M.; Han, K.; Beiki–Ardakani, A.; Borg, J.; Croke, J.; Ujaimi, R.; Levin, W.; Rink, A.; Xie, J.; Fyles, A.; Milosevic, M. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗